Capital Fund Management (CFM)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $35.3M | Sell |
71,088
-51,846
| -42% | -$23M | 0.16% | 145 |
|
|
2026
Q1 | $54.9M | Buy |
+122,934
| New | +$57.3M | 0.25% | 63 |
|
|
2024
Q2 | – | Sell |
-61,530
| Closed | -$25.7M | – | 2193 |
|
|
2024
Q1 | $25.7M | Buy |
+61,530
| New | +$26M | 0.07% | 347 |
|
|
2021
Q2 | – | Sell |
-17,577
| Closed | -$3.78M | – | 1676 |
|
|
2021
Q1 | $3.78M | Sell |
17,577
-36,888
| -68% | -$8.1M | 0.04% | 515 |
|
|
2020
Q4 | $12.9M | Sell |
54,465
-13,651
| -20% | -$3.13M | 0.12% | 204 |
|
|
2020
Q3 | $18.5M | Buy |
68,116
+48,783
| +252% | +$13.5M | 0.23% | 123 |
|
|
2020
Q2 | $5.61M | Buy |
+19,333
| New | +$5.24M | 0.09% | 282 |
|
|
2020
Q1 | – | Sell |
-10,432
| Closed | -$2.39M | – | 2062 |
|
|
2019
Q4 | $2.28M | Buy |
+10,432
| New | +$2.11M | 0.02% | 792 |
|
|
2019
Q2 | – | Sell |
-13,413
| Closed | -$2.47M | – | 1951 |
|
|
2019
Q1 | $2.47M | Sell |
13,413
-62,323
| -82% | -$11.5M | 0.02% | 730 |
|
|
2018
Q4 | $12.6M | Buy |
75,736
+6,072
| +9% | +$1.05M | 0.11% | 244 |
|
|
2018
Q3 | $13.4M | Sell |
69,664
-43,864
| -39% | -$7.81M | 0.07% | 381 |
|
|
2018
Q2 | $19.3M | Buy |
113,528
+62,300
| +122% | +$9.66M | 0.1% | 285 |
|
|
2018
Q1 | $8.35M | Sell |
51,228
-167,638
| -77% | -$27.4M | 0.05% | 497 |
|
|
2017
Q4 | $32.8M | Buy |
218,866
+56,700
| +35% | +$8.4M | 0.18% | 137 |
|
|
2017
Q3 | $24.7M | Buy |
162,166
+118,400
| +271% | +$17.8M | 0.18% | 163 |
|
|
2017
Q2 | $5.64M | Buy |
43,766
+6,487
| +17% | +$781K | 0.05% | 438 |
|
|
2017
Q1 | $4.08M | Buy |
+37,279
| New | +$3.28M | 0.03% | 549 |
|
|
2016
Q4 | – | Sell |
-63,578
| Closed | -$5.54M | – | 1876 |
|
|
2016
Q3 | $5.54M | Buy |
63,578
+50,779
| +397% | +$4.8M | 0.05% | 434 |
|
|
2016
Q2 | $1.1M | Buy |
+12,799
| New | +$1.11M | 0.01% | 928 |
|
|
2016
Q1 | – | Sell |
-195,893
| Closed | -$24.6M | – | 1875 |
|
|
2015
Q4 | $24.6M | Sell |
195,893
-83,252
| -30% | -$10.1M | 0.25% | 100 |
|
|
2015
Q3 | $29.1M | Buy |
279,145
+247,180
| +773% | +$31.8M | 0.33% | 67 |
|
|
2015
Q2 | $3.95M | Buy |
+31,965
| New | +$4.03M | 0.05% | 432 |
|
|
2015
Q1 | – | Sell |
-21,162
| Closed | -$2.51M | – | 1758 |
|
|
2014
Q4 | $2.51M | Buy |
21,162
+10,168
| +92% | +$1.15M | 0.03% | 627 |
|
|
2014
Q3 | $1.24M | Buy |
+10,994
| New | +$1.05M | 0.01% | 846 |
|
|
2013
Q3 | – | Sell |
-14,791
| Closed | -$1.18M | – | 1924 |
|
|
2013
Q2 | $1.18M | Buy |
+14,791
| New | +$1.09M | 0.02% | 758 |
|
Other funds holding VRTX
Capital Fund Management (CFM)'s VRTX Position: Q2 2026 in Review
Capital Fund Management (CFM) reduced its Vertex Pharmaceuticals (VRTX) stake by 42% in Q2 2026, selling an estimated $23M and leaving 71,088 shares worth $35.3M. The position accounts for 0.16% of the portfolio, ranked #145.
Capital Fund Management (CFM) first reported a position in VRTX in Q2 2013 and has held it in 25 quarters since. The position peaked at $54.9M in Q1 2026. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Capital Fund Management (CFM) held 71,088 shares of Vertex Pharmaceuticals worth $35.3M as of Q2 2026.
- Capital Fund Management (CFM) sold 51,846 Vertex Pharmaceuticals shares in Q2 2026, an estimated $23M.
- Vertex Pharmaceuticals made up 0.16% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #145 holding.
- Capital Fund Management (CFM) first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 25 quarters since.
- Capital Fund Management (CFM)'s Vertex Pharmaceuticals position peaked at $54.9M in Q1 2026.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.